The vasoactive peptide endothelin is shown to be a potent mitogen for Swiss 3T3 cells. Although endothelin has little effect on DNA synthesis when added alone to cells in serum-free medium, the peptide synergizes very strongly with several other growth factors. A half-maximal response to endothelin is observed at approx. 0.3 nm, with a maximal effect at 3 nm. Over the same concentration range, endothelin stimulates a 2-fold increase in the accumulation of cellular inositol phosphates. Endothelin may prove to be a useful additional agonist for studying the signalling pathways involved in the control of 3T3-cell proliferation.
INTRODUCTION
Endothelin, a 21-amino-acid peptide, was originally isolated from the medium conditioned by pig aortic endothelial cells (Yanagisawa et al., 1988) . The peptide is a potent vasoconstrictor through its activity on vascular smooth-muscle cells. Like other vasoconstrictors (e.g. vasopressin, angiotensin II), endothelin has been reported to stimulate the formation of inositol phosphates and Ca2" mobilization in these cells (Van Renterghem et al., 1988) . In addition, endothelin has been found to stimulate DNA synthesis in vascular smooth-muscle cells and in rat mesangial cells (Komuro et al., 1988; Nakaki et al., 1989; Simonson et al., 1989) .
Swiss 3T3 cells have been used extensively as a model system to study cell growth control and the signalling pathways activated by growth factors. The cells respond to several polypeptide mitogens, including epidermal growth factor (EGF), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF) and transforming growth factor ,3 (TGF, 8) . In addition, DNA synthesis and proliferation in these cells are also stimulated by the regulatory peptides vasopressin and bombesin (see Rozengurt, 1986 Brown & Blakeley (1983) . Stock cultures of Swiss mouse 3T3 cells were maintained and passaged as described (Brown & Blakeley, 1983 Brown & Blakeley (1983) . For measurement of formation of inositol phosphates, cells were pre-labelled for approx. 72 h by adding myo-
[3H]inositol (1 /tCi/ml) directly to the growth medium 3-4 days after seeding. The extraction and measurement of the total 3H-labelled inositol phosphate fraction (inositol mono-, bis-, tris-and tetrakis-phosphate) from mitogen-stimulated cells was performed as described previously (Heslop et al., 1986; Blakeley et al., 1989 Abbreviations used: EGF, epidermal growth factor; FGF, fibroblast growth factor; PDGF, platelet-derived growth factor; TGF/J, transforming growth factor f; IGF 1, insulin-like growth factor 1; TPA, 12-O-tetradecanoylphorbol acetate.
* To whom correspondence should be addressed. In contrast with the marked synergistic interactions described above, endothelin showed a limited ability to potentiate the mitogenic effect of insulin (Table 1) . Similarly, limited synergy was seen when insulin-like growth factor 1 (IGF 1) was tested in the concentration range 1-30 ng/ml (results not shown). This is an interesting result, since, under the same conditions, bombesin and vasopressin synergize very effectively with either insulin or IGFl (see Rozengurt, 1986) . Endothelin stimulates production of inositol phosphates in Swiss 3T3 cells Endothelin has been reported to stimulate phosphoinositide hydrolysis in vascular smooth-muscle cells (Resink et al., 1988; Van Renterghem et al., 1988) . We have therefore investigated the effect of endothelin on the formation of inositol phosphates in Swiss 3T3 cells. In the presence of LiCl, the peptide stimulated a 2-fold increase in the accumulation of inositol phosphates, with a maximal response at approx. 3 nM-endothelin (Fig. 2) (0) or protein kinase Cdepleted (0) cells were incubated in binding medium containing 121I-EGF (0.5 ng/ml) and the indicated concentration of endothelin for 45 min at 37 'C. The cells were washed, dissolved in 0.5 M-NaOH, and cell-associated radioactivity was measured as described by Brown & Blakeley (1983) . The values shown are the means for duplicate determinations of the percentage inhibition of 125I-EGF binding. The protein kinase C-depleted cells were prepared by adding TPA (300 nM) to the growth medium for 48 h before the experiment. TPA (10 nM) inhibited 125I-EGF binding by 820% and 9% in control and pretreated cultures respectively. in response to vasopressin, and considerably smaller than the response to bombesin, which causes up to 15-fold increases in the accumulation of inositol phosphates (see Blakeley et al., 1989; Brown et al., 1989) .
Inhibition of 125I-EGF binding by endothelin
In these and other cell types, the binding of 125I-EGF to its cellular receptors is inhibited by agonists which activate protein kinase C. The mechanism involves a decrease in receptor affinity after phosphorylation of its cytoplasmic domain by the kinase (see Schlessinger, 1986) . Endothelin inhibited '25I-EGF binding to Swiss 3T3 cells over a similar dose-response range as was found to stimulate phosphoinositide hydrolysis and DNA synthesis (Fig. 3) . In four separate experiments, the maximal inhibition observed varied between 340 and 500. Down-modulation of protein kinase C by prolonged pretreatment with TPA (see Stabel et al., 1987) decreased, but did not eliminate, the inhibitory effect of endothelin on 125I-EGF binding (Fig. 3) , suggesting that both protein kinase C-dependent and -independent pathways may be involved. The possibility that multiple pathways regulate EGF-receptor phosphorylation and affinity state has been suggested previously (Davis & Czech, 1987; Corps & Brown, 1988) .
DISCUSSION
Although discovered as a potent vasoconstrictor, endothelin has been found to stimulate DNA synthesis in vascular smooth-muscle cells, and it has been speculated that this effect might be related to the development of atherosclerosis (Komuro et al., 1988) . Simonson et al. (1989) (Yanagisawa et al., 1988; Resink et al., 1988; Van Renterghem et al., 1988; Hirata et al., 1988) . In Swiss 3T3 cells, Takuwa et al. (1989) reported that endothelin stimulated the production of inositol phosphates and diacylglycerol, and also enhanced phosphorylation of an 80 kDa acidic protein which is regarded as a marker substrate for activation of protein kinase C. In the present study, we observed a reproducible, but relatively small, stimulation of the accumulation of inositol phosphates in response to endothelin.
Activation of the inositol lipid signalling pathway has
Vol. 263 been implicated in the mechanism of action of several mitogens (see Whitman & Cantley, 1988) . Although endothelin shares with vasopressin and bombesin the ability to stimulate phosphoinositide hydrolysis in Swiss 3T3 cells, we have observed a number of differences between the mitogenic effects of the peptides. Firstly, vasopressin and bombesin synergize strongly with insulin to stimulate DNA synthesis (see Rozengurt, 1986) . In contrast, in the present experiments, the synergy between endothelin and insulin was much weaker than that observed between endothelin and other factors such as EGF or FGF. Secondly, endothelin synergizes strongly with TPA, whereas vasopressin does not synergize with this agent (Dicker & Rozengurt, 1980) . Finally, endothelin can synergize with bombesin or vasopressin to stimulate DNA synthesis. Taken together, these results suggest that the signalling pathways activated by these three mitogenic peptides may not be identical.
